Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation—Up to AF trial: Design and rationale

Novel anticoagulation therapy using apple watch after catheter ablation for atrial fibrillation—Up to AF trial: Design and rationale

Abstract Background Continuous anticoagulation based on the CHA2DS2‐VASc score is recommended to prevent embolism caused by atrial fibrillation (AF), but it does not consider AF episodes. The Apple Watch's continuous heart rhythm monitoring and fast‐acting direct oral anticoagulants (DOACs) cou...

Full description

Bibliographic Details
Main Authors: Akihiro Sunaga, Nobuaki Tanaka, Yasuyuki Egami, Hitoshi Minamiguchi, Takafumi Oka, Masato Kawasaki, Koichi Inoue, Masaharu Masuda, Miwa Miyoshi, Nobuhiko Makino, Tetsuya Watanabe, Daisaku Nakatani, Katsuki Okada, Hirota Kida, Yuki Matsuoka, Daisuke Sakamoto, Tetsuhisa Kitamura, Tomomi Yamada, Yohei Sotomi, Yasushi Sakata, the OCVC‐Arrhythmia Investigators
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of Arrhythmia
Subjects:
Apple Watch
atrial fibrillation
DOAC
tailored anticoagulation
Online Access:https://doi.org/10.1002/joa3.13194

Internet

https://doi.org/10.1002/joa3.13194

Similar Items